Anti-PD-1 immunotherapy in combination with sequential involved-site radiotherapy in heavily pretreated refractory Hodgkin lymphoma

1 Apr 2019Cancer/Radiothérapie

DOI : 10.1016/j.canrad.2018.05.002

Authors

L. Quéro, L. Gilardin, I. Fumagalli, V. Martin, S. Guillerm, O. Bauduceau, Y.M. Kirova, C. Hennequin, P. Brice